Mucormycosis: The Highly Fatal Fungal Disease Affecting COVID-19 Patients in India
In this podcast, the Infectious Diseases Society of America (IDSA) discusses mucormycosis: the deadly fungal infection affecting COVID-19 patients in India with IDSA and MSGERC members, Ilan Schwartz, MD, PhD, Assistant Professor in the Division of Infectious Diseases at the University of Alberta, and Andrej Spec, MD, MS, Associate Director of the Infectious Diseases Clinical Research Unit, Director of the Invasive Mycoses Clinic, and Assistant Professor of Medicine in the Division of Infectious Diseases at Washington University School of Medicine in St. Louis.
Topics covered include:
- The reasons for the explosion of mucormycosis in COVID-19 patients in India
- Strategies for addressing corticosteroid dosages, diabetes control, and medical/surgical management of mucormycosis affecting COVID-19 patients in India
- Strategies patients can apply to protect themselves in terms of corticosteroid use, glucose control, and use of over-the-counter medications
- International public health strategies to improve the situation in India, including vaccine access and research
© 2023 MSGERC and Terranova Medica LLC. All rights reserved.